In MASH with moderate or advanced liver fibrosis, weekly semaglutide improved histologic steatohepatitis and fibrosis at 72 wk. Imperiale TF. Ann Intern Med 2025 Sep 2. doi: 10.7326/ANNALS-25-03308.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Imperiale TF. In MASH with moderate or advanced liver fibrosis, weekly semaglutide improved histologic steatohepatitis and fibrosis at 72 wk. Ann Intern Med 2025 Sep 2. doi: 10.7326/ANNALS-25-03308.
PMID: 40889372